Opening Day: Cancer 'Killer' Nkarta Soars After Coming Public
July 12, 2020 at 14:44 PM EDT
Nkarta, which is developing "natural killer-based cell therapies" to treat cancer saw its stock surge on its first day of public trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|